Skip to content Skip to main navigation


Give your company an edge with online courses from Harvard Medical School.

Harvard Medical School offers a unique online learning experience for professionals who want to understand medical science – from essential concepts to cutting-edge applications.

HMX courses are recommended for companies that want to:

  • gain a competitive advantage by helping employees better understand the medical science needed to do their jobs more effectively
  • enable cross-functional teams to communicate and collaborate better
  • deliver a flexible, accessible learning experience to employees worldwide

“Taking the HMX courses taught me a lot about what it’s like to be an adult professional who has a job and a family who also wants to learn.”

Lina Scroggins
Senior Program Manager, Google Health

Hear how Lina found her way to a career in the health care industry and learning with HMX.

Companies including Google, Novartis, and Moderna have offered HMX courses to employees to emphasize the role of learning in keeping pace with change. Learn more about discounts and enrollment options by filling out the form below.


Course Offerings


The HMX Pro series was designed to help busy professionals get up to speed on the latest advances in fields like genetics, immunology, and pharmacology, from essential concepts to cutting-edge applications. Advanced topics include cancer genomics and precision oncology; immuno-oncology; genetic testing and sequencing technologies; drug delivery; vaccines and viral immunology; and novel therapies for chronic inflammation, autoimmunity, and allergy.

HMX Fundamentals

The HMX Fundamentals series features in-depth overviews of foundational science topics and their clinical applications, appropriate for a range of learners and applications. Available courses include immunology, genetics, pharmacology, biochemistry, and physiology.

HMX Short Courses

HMX Short Courses feature targeted lessons on the latest medical science topics and advancements to keep learners up to date. A range of courses covering immunology and artificial intelligence topics are currently available.

Why HMX?

Learn how professionals in a variety of roles have gained value from HMX courses.

“Though I was familiar with certain processes and the vocabulary was very familiar to me, the application to immunology in this level of detail was not…for my own personal understanding it’s made a world of difference.”

Allie Hyans
Manager of Business Development & Global Alliances

“What I liked about the course was it focused a lot on the disease areas and the applications of the biology…I definitely think it should help me with my everyday work.”

Sally Yuan
Senior Associate Scientist
Janssen Pharmaceuticals

“I’ve found all the courses to be tremendously helpful. The topics are so well organized, and I think the lectures cover those fundamental ideas very well…they are challenging in a positive way.”

Siyan Xu
Senior Principal Biostatistician

“The class provided a really great foundation of learning about the immune system…the professors were great, the videos were extremely well done, the lessons were the right length and were engaging.”

Emily M.
Biotech business development executive

“HMX gives us the opportunity to meet the need for more medical training and more awareness about medical topics”

Irene Nyavor
Program Manager, Google

“I do a little bit of learning through osmosis in my job, because we do analysis on genetic data, so I learn kind of as I go. But [HMX] has helped push me forward greatly.”

David Hall

“The learning objectives at the beginning, then all of the concepts through the story and the videos, and then the linkage to disease, I thought that was amazing. For me that was the most valuable part.”

Laura Gonzalez
Corporate Development Manager

“The way the HMX course was designed tells the story in a way that you can string the pieces together…I was definitely able to follow the progression of the immune response. And the disease linkages just kind of really punctuated it all, to connect it to real life and medicine and patients.”

Pharmaceutical research director